Keyword: Richard Gonzalez
AbbVie CFO Bill Chase will retire in 2019 after helming finance since the company's birth in 2013. He'll be replaced by controller Robert Michael.
AbbVie donated $100 million to Ronald McDonald House Charities this week, part of its ongoing 2018 tax-windfall handout of $350 million to charities.
AbbVie is bracing for European biosimilar competition to Humira, but the drug is still continuing its upward trajectory.
If you thought AbbVie CEO Richard Gonzalez spent a lot on personal air travel in 2016, check out 2017’s numbers.
The benefits of the upcoming tax overhaul will be so great that AbbVie is planning $2.5 billion in capital projects in the U.S.
AbbVie took a big step toward putting investors’ minds at ease about aging blockbuster Humira, with better-than-expected third-quarter results.
Facing backlash over reports that execs considered abandoning their pricing pledge, AbbVie said it's committed—at least through next year.
AbbVie turned in better-than-expected second quarter results, but investors remained focused on whether pipeline prospects will make up for the eventual decline of Humira.